KKR is close to selling capsule maker Capsugel to Swiss drug maker Lonza for more than $5bn.
Tag Archives | pharmaceuticals
German venture capital-backed cancer drug maker Ganymed Pharmaceuticals has been acquired by Japanese pharma company Astellas Pharma for €422 million.
The Japanese firm owns a pharmacy chain and a nursing care provider.
Kenyan private equity firm Catalyst Principal Partners has acquired pharmaceutical manufacturer Zenufa Laboratories.
The firm saw the growing trend in pharma companies to outsource internal functions as an opportunity to invest in ProPharma.
Temasek and ChrysCapital-backed Indian drug company Intas has acquired Actavis UK and Ireland from Teva Pharmaceutical for £600 million.
Government intervention in drug pricing and more stringent regulation is pushing domestic pharmaceutical companies to acquire foreign assets.
San Francisco’s Altamont Capital Partners has sold speciality pharmacy Modern Healthcare to retailer The Kroger Company.
In the first of a two-part series, Robert Hatch of Constitution Capital Partners explores some key takeaways for investors through analyzing over 1,000 healthcare buyouts, dating back to 1987.
Big pharma debt loads are spurring non-core divestment and creating opportunities for private equity carve-outs, GTCR managing director Sean Cunningham tells PHI.